Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.22.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 765 $ 14,471 $ 39,050,260 $ (23,648,898) $ (1,893,897) $ 13,522,701
Beginning balance, shares at Dec. 31, 2020 764,618 14,471,403        
Sale of common stock - investors $ 1,500 3,253,500 3,255,000
Sale of common stock - investors, shares   1,500,000        
Issuance of common stock - note holders $ 5,878 11,510,814 11,516,692
Issuance of common stock - note holders, shares   5,877,908        
Issuance of common stock - consultants $ 943 2,035,392 2,036,335
Issuance of common stock - consultants, shares   943,000        
Issuance of common stock - employees $ 1,263 3,290,927 3,292,190
Issuance of common stock - employees, shares   1,262,872        
Issuance of common stock - exercise of warrants $ 881 1,689,723 1,690,604
Issuance of common stock - exercise of warrants, shares   880,798        
Exercise of warrant liabilities 259,427 259,427
Issuance of common stock for acquisition $ 750 1,251,750 1,252,500
Issuance of common stock for acquisition, shares   750,000        
Share-based compensation   3,660,436 3,660,436
Net income (62,469,354) 28,034 (62,441,320)
Ending balance, value at Mar. 31, 2021 $ 765 $ 25,686 66,002,229 (86,118,252) (1,865,863) (21,955,435)
Ending balance, shares at Mar. 31, 2021 764,618 25,685,981        
Beginning balance, value at Dec. 31, 2021 $ 150,118 850,096,635 (736,821,840) 20,262,129 133,687,042
Beginning balance, shares at Dec. 31, 2021 150,118,024        
Issuance of common stock - consultants   $ 40 (40)    
Issuance of common stock - exercise of warrants $ 36,895 110,992,598 111,029,493
Issuance of common stock - exercise of warrants, shares   36,934,569        
Exercise of warrant liabilities 100,029,044 100,029,044
Share-based compensation 102,563 1,040,882 1,143,445
Net income (372,947,957) (6,157,190) (379,105,147)
Conversions under notes payable   $ 1,000 2,179,000     2,180,000
Conversions under notes payable, shares   1,000,000        
Offering costs upon exercise of warrants (9,992,654) (9,992,654)
Ending balance, value at Mar. 31, 2022 $ 188,053 $ 1,053,407,146 $ (1,109,769,797) $ 15,145,821 $ (41,028,777)
Ending balance, shares at Mar. 31, 2022 188,052,593